0001127602-17-005421.txt : 20170213
0001127602-17-005421.hdr.sgml : 20170213
20170213162545
ACCESSION NUMBER: 0001127602-17-005421
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170209
FILED AS OF DATE: 20170213
DATE AS OF CHANGE: 20170213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001062822
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 760474169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8800 TECHNOLOGY FOREST PLACE
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
BUSINESS PHONE: 2818633000
MAIL ADDRESS:
STREET 1: 8800 TECHNOLOGY FOREST PLACE
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE
DATE OF NAME CHANGE: 20070426
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON GENETICS INC/TX
DATE OF NAME CHANGE: 20000126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lapuerta Pablo
CENTRAL INDEX KEY: 0001516368
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30111
FILM NUMBER: 17599521
MAIL ADDRESS:
STREET 1: 8800 TECHNOLOGY FOREST PLACE
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-02-09
0001062822
LEXICON PHARMACEUTICALS, INC.
LXRX
0001516368
Lapuerta Pablo
8800 TECHNOLOGY FOREST PLACE
THE WOODLANDS
TX
77381
1
EVP and CMO
Stock Option (Right to Buy)
14.44
2017-02-09
4
A
0
41370
0
A
2027-02-09
Common Stock
41370
41370
D
Restricted Stock Units (Phantom Stock)
2017-02-09
4
A
0
10340
0
A
Common Stock
10340
10340
D
Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/9/2018) and vests 1/48th per month for each month of service thereafter
Each restricted stock unit represents a contingent right to receive one share of common stock.
Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
/s/ Pablo Lapuerta, M.D.
2017-02-13